[Smell the smoke before one sees the fire-The oligosymptomatic prodromal phase of neurodegenerative diseases].

Biomarker-based identification of individuals in the prodromal phase of neurodegenerative diseases is already possible for some entities. People who show the first signs of a neurodegenerative disease can be referred to centers for clinical trials and observational studies.